Video

Ted Okon Talks About the Issues With Reimbursement

Author(s):

Ted Okon

Ted Okon Talks About the Issues With Reimbursement

Ted Okon the Executive Director of the Community Oncology Alliance (COA) Talks About the Issues With Reimbursement

Related Videos
Fred Saad, CQ, MD, FRCS, FCAHS
Eric Kumar Singhi, MD
Seth Wander, MD, PhD
Lillian L. Siu, MD, FRCPC
Marc Machaalani, MD
Mark Awad, MD, PhD, chief, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center
Rasha Cosman, BSc, MBBS, FRACP
Saad Z. Usmani, MD, MBA, FACP, FASCO
Nicholas P. McAndrew, MD, MSCE
Xichun Hu, MD, PhD
Related Content
Jeff Patton, MD
September 24th 2024

Medicare Drug Price Negotiations Will Have Domino Effect for Community Oncology Practices

Sorting Through Sexism, Guilt, and Motherhood in Medicine
January 27th 2022

Sorting Through Sexism, Guilt, and Motherhood in Medicine

Debra Patt, MD, PhD, MBA, FASCO, of Texas Oncology
September 5th 2024

Medicare Drug Price Negotiation Program Will Result in Financial Burdens for Community Oncology Practices

Gilbert on Gaining New Ground at Vanderbilt
January 3rd 2022

Gilbert on Gaining New Ground at Vanderbilt

Debra Patt, MD, PhD, MBA, FASCO
September 3rd 2024

Vice President of COA Unpacks Effects of the Medicare Drug Price Negotiation Program in the Community

Marjorie Green, MD
August 29th 2024

Merck to Discontinue KEYNOTE-867 and KEYNOTE-630 Trials of Pembrolizumab in NSCLC, CSCC